If you need more lookups,
subscriptions start at $34 USD/month.
George Pope Location
Oxford, GB
George Pope Work
Director Non-clinical and Translational Science @ (April 2025 - Present)
Associate Director Preclinical Safety @ (March 2023 - April 2025)
Group Leader - Preclinical Safety @ (January 2020 - March 2023)
Senior Scientist @ (January 2016 - January 2020)
Scientist @ (September 2014 - December 2015)
Post-Doctoral Research Assistant in Hormone Signalling @ (January 2013 - March 2014)
Research Postgraduate @ (October 2008 - October 2012)
Research Assistant @ (February 2007 - September 2008)
George Pope Education
University of Bristol
Doctor of Philosophy (PhD) (Neuroendocrinology)
2008-2012
University of Kent
Bachelor of Science (BSc) (Molecular and Cellular Biology)
2003-2006
George Pope Skills
Biotechnology
Budget Management
Cancer Biology
Cancer Immunotherapy
Career Management
Cell Biology
Cell Culture
Cell Therapy
Communication
Constructive Feedback
Drug Development
ELISA
Establishing Relationships
General Management
GraphPad Prism
Immunohistochemistry
Immunology
In Vitro
In Vivo
Leadership
Microscopy
Molecular Biology
Neuroscience
Non-clinical
PCR
Pre-clinical Studies
Presentation Skills
Presentations
Problem Solving
Program Leadership
Project Management
Protein Expression
Regulatory Submissions
Research Skills
Research and Development (R&D)
Scientific Writing
Stakeholder Management
T cells
Team Leadership
Team Management
Timelines
Tumor Immunology
Western Blotting
George Pope Summary
George Pope, based in Oxford, GB, is currently a Director Non-clinical and Translational Science at Blue Earth Diagnostics. George Pope brings experience from previous roles at Adaptimmune. George Pope holds a 2008 - 2012 Doctor of Philosophy (PhD) in Neuroendocrinology @ University of Bristol. With a robust skill set that includes Biotechnology, Budget Management, Cancer Biology, Cancer Immunotherapy, Career Management and more. George Pope has 1 emails on RocketReach.
Looking for a different George Pope?
Find contact details for 700 million professionals.